What the weight loss injections price increase means for UK patients in 2025

Step 1: Understand what actually changed and why it matters

The Lilly list-price revision in September 2025 was not subtle. As widely reported at the time, the wholesale price of certain Mounjaro pens more than doubled at the higher doses, the 15mg pen moved from a list price of around £122 to around £330, with other strengths adjusting proportionally. Private providers, who source through the licensed UK supply chain, absorb those input costs or pass them on. Most passed them on.

That context matters when you see a range of current prices across the market. A provider quoting significantly below the new supply-chain cost is either operating on wafer-thin margins, sourcing from a different (potentially unverified) channel, or using introductory pricing that will not last. The full breakdown of current UK injection pricing explains the dose-by-dose picture in more detail. For now, the key fact is that the market-wide price floor moved, and any offer that appears to ignore that deserves scrutiny.

Semaglutide (Wegovy) pricing has followed a broadly similar trajectory, though Novo Nordisk's list-price history differs from Lilly's. The clinical trial evidence (including SURMOUNT-1, published in the New England Journal of Medicine) established tirzepatide's efficacy profile, but the cost of accessing that evidence-based treatment in the UK is now higher than it was eighteen months ago. That is simply the reality.

Step 2: Look beyond the headline figure at what the price actually covers

A quoted monthly price for weight loss injections can mean very different things depending on the provider. Some headline prices cover the pen only. Consultation fees, prescription charges, delivery costs, and aftercare are then billed separately, sometimes per interaction. A patient who compares a £149 headline figure with a higher all-in price and concludes the lower one is cheaper may find the gap narrows or reverses once those add-ons land.

The things most likely to be excluded from a low headline price: the initial clinical consultation (which can run from £20 to £75+ at some services), the written prescription, delivery (especially tracked, next-working-day delivery), and any follow-up clinical support when you have questions about how treatment is going. If you need a dose review, some providers charge again. Our guide to how injection prices are structured walks through what to check before committing to any provider.

NHS England's guidance on weight-management injections notes that clinical supervision is an expected part of legitimate treatment, not an optional extra. That supervision has a cost, and providers who absorb it into a single price are making a different commercial choice from those who separate it out. Neither is automatically wrong, but you need to know which model you're in.

Step 3: Place the price in the right frame, clinical safety, not cost comparison

A price increase on a prescription medicine is genuinely difficult news for people who rely on it. That said, the question of who to buy from should not be decided by cost alone, and the post-increase market makes that more important, not less. When input prices jump, the temptation for some sellers to cut corners on clinical oversight or supply-chain integrity increases alongside them.

The MHRA has warned publicly about fake weight-loss pens sold online, including counterfeit tirzepatide pens. In 2025 approximately 20 million doses of illegally traded weight-loss medicines (around £45 million street value) were seized, and the first UK site producing counterfeit tirzepatide pens was raided. Fake pens have in some cases contained insulin. If a price looks untouched by the real supply-chain movement since September 2025, that is a question worth asking. You can verify any online pharmacy on the GPhC register; a pharmacy that cannot be found there should not be dispensing prescription medicines to you.

Price is the wrong test for a prescription medicine. The right questions are: is this pharmacy GPhC-registered, is a real prescriber reviewing my case, and is the medicine coming from the licensed UK supply chain? Those are the measures that keep you safe. Our page on finding affordable injections addresses this directly, including what legitimate cost-reduction looks like and what it doesn't.

Step 4: What to expect at a regulated service after the price change

At nume, the price increase affected our supply costs, as it did every provider sourcing through the authorised UK chain. We are not the cheapest option in the market, and that is a deliberate choice, not an oversight. What the single price you see on our treatment page includes: the clinical consultation, the prescription, the medicine, and free next-working-day tracked delivery by DPD in plain packaging. Aftercare is included and runs seven days a week. There are no subscriptions, no auto-renewal charges, and every repeat order gets a fresh clinical review by a named GPhC-registered prescriber before anything is approved or sent.

If you are already on treatment elsewhere and concerned about rising costs, it is worth a conversation. Our overview of injectable weight loss treatments sets out what is licensed in the UK, how eligibility works, and what the clinical pathway looks like, a useful starting point if you want to compare properly. The cost of weight loss injections page adds further context on how providers structure their pricing post-increase, and if budget is a genuine concern, our guide to affordable weight loss injections explains where it is and is not realistic to expect savings without compromising on safety. Current treatment pricing at nume is shown on the treatment page; our prescribers and aftercare team are reachable via our contact page if you have specific questions before you start.